Stabilized oral prostaglandin formulation and the process for the preparation thereof
US4113882A · kind A · utility
44Cited by
1References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 13, 1976 |
| Grant date | Sep 12, 1978 |
| Priority date | — |
| Expiry date | May 13, 1996 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C405/00
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
There is disclosed a dry, stabilized oral pharmaceutical formulation containing a prostaglandin E group prepared from a lyophilized composition comprising a prostaglandin E group and at least a member selected from the group consisting of a thiol compound, dextrin, dextran, a lower alkyl cellulose, and a water-soluble salt of deoxycholic acid.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.